Table 4 The association between rs2239647 and glioma patient OS and PFS
From: Impact of AKAP6 polymorphisms on Glioma susceptibility and prognosis
rs2239647 | Genotype | OS | PFS | ||||||
|---|---|---|---|---|---|---|---|---|---|
Log-rank p | SR (1−/3-year) | HR (95%CI) | p | Log-rank p | SR (1−/3-year) | HR (95%CI) | p | ||
CC | 0.227 | 0.328/0.080 | 1.00 | 0.413 | 0.182/0.084 | 1.00 | |||
CA | 0.327/0.134 | 1.15 (0.86–1.54) | 0.346 | 0.193/0.122 | 1.13 (0.84–1.51) | 0.424 | |||
AA | 0.224/0.034 | 0.91 (0.76–1.10) | 0.325 | 0.138/0.039 | 0.94 (0.78–1.13) | 0.517 | |||
Low-grade glioma(I–II) | |||||||||
CC | 0.124 | 0.324/0.077 | 1.00 | 0.267 | 0.159/− | 1.00 | |||
CA | 0.349/0.165 | 0.96 (0.66–1.39) | 0.818 | 0.232/0.147 | 0.93 (0.64–1.35) | 0.686 | |||
AA | 0.270/− | 0.80 (0.64–1.01) | 0.065 | 0.189/− | 0.84 (0.66–1.06) | 0145 | |||
High-grade glioma (III–IV) | |||||||||
CC | 0.056 | 0.333/0.085 | 1.00 | 0.045 | 0.219/0.092 | 1.00 | |||
CA | 0.279/− | 1.61 (1.04–2.66) | 0.035 | 0.106/− | 1.67 (1.04–2.67) | 0.034 | |||
AA | 0.143/− | 1.19 (0.87–1.63) | 0.268 | 0.048/− | 1.21 (0.88–1.66) | 0.233 | |||